You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adenomyosis

Showing 26 - 50 of 277
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

II: Gene Expression Profiling of Adenomyosis

Active, not recruiting
  • Adenomyosis
  • Myometrial biopsy
  • endometrial biopsy
  • Oslo, Norway
    Gynecological department, Oslo University Hospital, Ullevål
Mar 3, 2021

Endometriosis Trial in Montigny-le-Tilleul (ENDO 1/ENDO 2, Placebo)

Completed
  • Endometriosis
  • ENDO 1/ENDO 2
  • Placebo
  • Montigny-le-Tilleul, Hainaut, Belgium
    CHU Vésale
Mar 20, 2022

Adenomyosis: Genomic Mechanisms and Biological Response

Withdrawn
  • Adenomyosis
  • Abnormal Uterine Bleeding
  • (no location specified)
Jan 28, 2021

Norwegian Adenomyosis Study III: Peristalsis

Terminated
  • Adenomyosis
  • +2 more
    • Oslo, Norway
      Department of Gynecology, Oslo University Hospital Ullevål and R
    Mar 3, 2021

    Adenomyosis, Assisted Reproductive Technology Trial in Nanjing (Low molecular weight heparin)

    Active, not recruiting
    • Adenomyosis
    • Assisted Reproductive Technology
    • Low molecular weight heparin
    • Nanjing, Jiangsu, China
      Reproductive Medicine Center, The affiliated Drum Towel Hospital
    Feb 3, 2021

    Adenomyosis Trial in London (GnRH analogue downregulation, Participant questionnaire)

    Recruiting
    • Adenomyosis
    • GnRH analogue downregulation
    • Participant questionnaire
    • London, United Kingdom
      University College London Hospital
    Feb 11, 2021

    Menstrual Problem, Quality of Life Trial in Istanbul (not included any interventions(Evaluation of menstrual well-being in women

    Completed
    • Menstrual Problem
    • Quality of Life
    • not included any interventions(Evaluation of menstrual well-being in women of reproductive age, field survey study)
    • Istanbul, Turkey
      Kartal Dr. Lutfi Kirdar Research and Training Hospital
    Jun 30, 2022

    Adenomyosis, Chronic Pelvic Pain Trial (LNG-IUS 13,5 mg Levonorgestrel, Levonorgestrel 0,10 mg+ ethinylestradiol 0,02 mg)

    Unknown status
    • Adenomyosis
    • Chronic Pelvic Pain
    • LNG-IUS 13,5 mg Levonorgestrel
    • Levonorgestrel 0,10 mg+ ethinylestradiol 0,02 mg
    • (no location specified)
    Feb 3, 2021

    Adenomyosis Trial in Hong Kong (HIFU treatment)

    Active, not recruiting
    • Adenomyosis
    • HIFU treatment
    • Hong Kong, Hong Kong
      (unnamed)
    Sep 16, 2020

    Adenomyosis of Uterus Trial (Aspirin/)

    Unknown status
    • Adenomyosis of Uterus
    • Aspirin/placebo
    • (no location specified)
    Aug 27, 2020

    Endometriosis, Adenomyosis Trial in Paris (Biological/Vaccine)

    Recruiting
    • Endometriosis
    • Adenomyosis
    • Biological/Vaccine
    • Paris, France
      Port Royal, hospital cochin
    Jul 17, 2020

    Adenomyosis Trial in Assiut (drug, radiation, other)

    Completed
    • Adenomyosis
    • Dienogest group
    • +3 more
    • Assiut, Egypt
      Women Health Hospital - Assiut university
    Aug 22, 2020

    Validation of the Adenomyosis Calculator

    Recruiting
    • Adenomyosis
    • Pelvic Pain Syndrome
      • Turku, Finland
      • +4 more
      Feb 12, 2020

      Cervix Tumors, Endometrial Cancer, Adenomyosis Trial in Nanjing (the drug of intravenous patient-controlled analgesia)

      Unknown status
      • Cervix Neoplasms
      • +3 more
      • the drug of intravenous patient-controlled analgesia
      • Nanjing, Jiangsu, China
        The First Affiliated Hospital with Nanjing Medical University
      Apr 21, 2020

      Adenomyosis Trial (Microwave treatment via needle antenna, Embolization of uterine artery or branches thereof (routine treatment

      Unknown status
      • Adenomyosis
      • Microwave treatment via needle antenna
      • Embolization of uterine artery or branches thereof (routine treatment where polyvinyl alcohol particles are released into the predefined bloodstream)
      • (no location specified)
      Dec 20, 2019

      Adenomyosis Trial in Hangzhou (Mifepristone, Placebo)

      Completed
      • Adenomyosis
      • Hangzhou, Zhejiang, China
        Women's Hospital of Zhejiang Medical University
      Oct 1, 2019

      Cervical Cancer, Ovarian Tumor, Endometrial Carcinoma Trial in Guangzhou (Intravenous ICG and Real-Time Near-infrared Imaging)

      Recruiting
      • Cervical Cancer
      • +8 more
      • Intravenous ICG and Real-Time Near-infrared Imaging
      • Guangzhou, Guangdong, China
        Southern Medical Universtity, China
      Jan 12, 2020

      Pathogenesis of Malignant Transformation of Adenomyosis

      Unknown status
      • Adenomyosis
      • +5 more
      • whole exome sequencing and RNA-sequencing
      • Beijing, Beijing, China
        Lei Li
      Jul 16, 2019

      Pro-inflammatory Cytokines in Case of Essure®

      Recruiting
      • Inflammatory Disease
      • pro-inflammatory cytokines
      • Bron, France
        Gynaecology Department, Hôpital Femme Mère Enfant Hospices Civis
      Jul 12, 2023

      Cesarean Section; Dehiscence Trial (Zoladex)

      Not yet recruiting
      • Cesarean Section; Dehiscence
      • (no location specified)
      Jan 11, 2022

      Iron Proteinsuccinylate Oral Solution(FERPLEX) in Gynecologic

      Not yet recruiting
      • Patients With Iron Deficiency Anemia in Gynecology
        • (no location specified)
        Feb 13, 2022

        Impact of Incomplete Endometrial Ablation

        Enrolling by invitation
        • Heavy Menstrual Bleeding
        • hysteroscopy
        • Veldhoven, Noord-Brabant, Netherlands
          Máxima MC
        Nov 5, 2023

        Uterine Fibroids, Adenomyosis Trial in Turku (MRI-HIFU)

        Recruiting
        • Uterine Fibroids
        • Adenomyosis
        • MRI-HIFU
        • Turku, Finland
          Turku University Hospital
        Apr 26, 2019

        Fibroid, Adenomyosis Trial in Turku (Oxytocin)

        Unknown status
        • Fibroid
        • Adenomyosis
        • Turku, Finland
          Turku University Hospital
        May 2, 2019

        CS Scar Impact on ART Outcomes

        Recruiting
        • Fertility Issues
          • Abu Dhabi, United Arab Emirates
            HealthPlus fertility Centre
          Aug 28, 2023